Simple blood test predicts neurotoxic complications of CAR-T cell therapy
A new study suggests a simple blood test — administered before CAR-T cell treatment is initiated — may identify which patients are predisposed to developing neurotoxic side effects in the days and weeks after CAR-T cell therapy.
Materials provided by Washington University School of Medicine. Original written by Julia Evangelou Strait. Note: Content may be edited for style and length.
Source link aaaaa